dave asprey bpc 157 Fabulous time recording with @dave.asprey for his @thehumanupgradepodcast Dave's depth of knowledge in science, biohacking, longevity, and human performance is incredible. Loved the chance to go deep on the microbiome, health optimization Fresenius Kabi

Tore my rotator cuff and my friend @lindsythenp @regener8lifeclinic was on it! BPC-157 is a peptide currently experimental but used off label for muscle and cartilage regeneration. I highly recommend ...

According to British Society for Haematology (BSH) guidelines and NICE Clinical Knowledge Summaries (CKS), the primary beneficiaries include: Key patient groups who may require B12 injections include: Pernicious anaemia patients – requiring lifelong hydroxocobalamin 1mg intramuscularly every 2–3 months following initial loading doses Patients with gastrointestinal disorders – including those who have undergone gastrectomy or ileal resection, and patients with conditions affecting B12 absorption such as Crohn's disease or coeliac disease Strict vegans and vegetarians – though oral supplementation is usually sufficient unless malabsorption is present Elderly patients – who may have reduced gastric acid production affecting B12 absorption Patients taking certain medications – including metformin (MHRA advises monitoring B12 levels in long-term users, particularly those with risk factors or symptoms), proton pump inhibitors, and H2-receptor antagonists long-term [6] Individuals with neurological symptoms – such as paraesthesia, ataxia, or cognitive impairment related to B12 deficiency Pregnant women – with confirmed deficiency (hydroxocobalamin for malabsorption

Fresenius Kabi

Pack Size:Single

B12 Injection Results Timeline at a Glance Timing is individual